Montana Compounding Pharmacy Recalls Alprostadil Injectable Due to Sterility Concerns
Montana Compounding Pharmacy is recalling Alprostadil injectable vials due to lack of assurance of sterility and objectionable conditions observed during an FDA inspection.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in an injectable medication, which poses a significant risk of serious injury or infection.
Plain-English summary
Montana Compounding Pharmacy is recalling Alprostadil (PFE1), solution, 30 mcg/mL, injectable, 5 mL vials. The recall was initiated due to a lack of assurance of sterility and objectionable conditions observed during a U.S. Food and Drug Administration (FDA) inspection.
The affected product is prescription-only and was distributed in Montana and North Dakota. The specific lot number is 04062015:18@1, with an expiration date of August 1, 2015.
Patients and healthcare providers should stop using the recalled product and contact their healthcare provider for further instructions or to obtain a replacement.
The recalled product
- Product
- Alprostadil (PFE1), solution, 30 mcg/mL, injectable, 5 mL vial, Rx only, compounded by Montana Compounding Pharmacy, Missoula, MT
- Manufacturer
- Montana Compounding Pharmacy
- Category
- Drug — Injectable
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot 04062015:18@1. Expiry date: 8/1/2015
Distribution
Part of a larger recall action
This product is one of 12 recalled by Montana Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 12 products in this recall →Related recalls
Same manufacturer · Montana Compounding Pharmacy
See all →- SevereMontana Compounding Pharmacy Recalls Trimix Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-06-17
- SevereMontana Compounding Pharmacy Recalls Hyaluronidase Injectable Solution Due to Sterility Concerns
FDA (Drugs) · 2015-06-17
- SevereMontana Compounding Pharmacy Recalls Glutathione Inhalation Solution Due to Sterility Concerns
FDA (Drugs) · 2015-06-17
- SevereMontana Compounding Pharmacy Recalls Glutathione Nasal Solution Due to Sterility Concerns
FDA (Drugs) · 2015-06-17
- SevereMontana Compounding Pharmacy Recalls Alprostadil Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-06-17
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29